AIM IMMUNOTECH INC. Capital Expenditures
AIM IMMUNOTECH INC. (AIM) reported Capital Expenditures of $18.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-27
- AIM IMMUNOTECH INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00.
- AIM IMMUNOTECH INC. payments to acquire property, plant, and equipment for the quarter ending 2021-12-31 was $7.00K, a 22.22% decline year-over-year.
- AIM IMMUNOTECH INC. payments to acquire property, plant, and equipment for the quarter ending 2021-09-30 was $8.00K, a 100.00% increase year-over-year.
- AIM IMMUNOTECH INC. payments to acquire property, plant, and equipment for the quarter ending 2020-12-31 was $9.00K.
- AIM IMMUNOTECH INC. payments to acquire property, plant, and equipment for fiscal 2024 was $18.00K.
- AIM IMMUNOTECH INC. payments to acquire property, plant, and equipment for fiscal 2022 was $86.00K, a 109.76% increase from fiscal 2021.
- AIM IMMUNOTECH INC. payments to acquire property, plant, and equipment for fiscal 2021 was $41.00K, a 86.36% increase from fiscal 2020.
- AIM IMMUNOTECH INC. payments to acquire property, plant, and equipment for fiscal 2020 was $22.00K, a 67.65% decline from fiscal 2019.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $18.00K 10-K · filed 2026-03-27 | ||
| 2024-09-30 | $18.00K 10-Q · filed 2025-11-17 | |||
| 2023-09-30 | $10.00K 10-Q · filed 2024-11-14 | |||
| 2022-12-31 | $86.00K 10-K · filed 2024-04-01 | |||
| 2021-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $15.00K derived: sum of 2 quarters · filed 2023-03-31 | $41.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $34.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $26.00K 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $13.00K derived: sum of 2 quarters · filed 2022-03-31 | $15.00K derived: sum of 3 quarters · filed 2022-03-31 | $22.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $6.00K derived: sum of 2 quarters · filed 2021-11-15 | $13.00K 10-Q · filed 2021-11-15 | $13.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $9.00K 10-Q · filed 2021-08-16 | $9.00K derived: sum of 3 quarters · filed 2021-08-16 | $14.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $7.00K 10-Q · filed 2021-05-17 | $7.00K derived: sum of 2 quarters · filed 2021-05-17 | $12.00K derived: sum of 3 quarters · filed 2021-05-17 | $61.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $5.00K derived: sum of 2 quarters · filed 2021-03-31 | $54.00K derived: sum of 3 quarters · filed 2021-03-31 | $68.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $54.00K derived: sum of 2 quarters · filed 2020-11-12 | $68.00K 10-Q · filed 2020-11-12 | $71.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $63.00K 10-Q · filed 2020-08-14 | $66.00K derived: sum of 3 quarters · filed 2020-08-14 | |
| 2019-03-31 | $14.00K 10-Q · filed 2020-05-14 | $17.00K derived: sum of 2 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $51.00K 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $48.00K 10-Q · filed 2019-11-14 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $17.00K derived: sum of 2 quarters · filed 2019-04-01 | $17.00K derived: sum of 3 quarters · filed 2019-04-01 | $20.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $17.00K derived: sum of 2 quarters · filed 2018-11-14 | $20.00K 10-Q · filed 2018-11-14 | $20.00K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $3.00K 10-Q · filed 2018-08-14 | $3.00K derived: sum of 3 quarters · filed 2018-08-14 | $3.00K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $3.00K 10-Q · filed 2018-05-15 | $3.00K derived: sum of 2 quarters · filed 2018-05-15 | $3.00K derived: sum of 3 quarters · filed 2018-05-15 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $0.00 derived: sum of 2 quarters · filed 2018-03-30 | $160.00K 10-K · filed 2018-03-30 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $160.00K 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $160.00K 10-Q · filed 2017-08-14 | |||
| 2015-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $0.00 derived: sum of 2 quarters · filed 2018-03-30 | $193.00K derived: sum of 3 quarters · filed 2018-03-30 | $240.00K 10-K · filed 2018-03-30 |
| 2015-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $179.00K derived: sum of 2 quarters · filed 2016-11-14 | $226.00K 10-Q · filed 2016-11-14 | $344.00K derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-06-30 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $240.00K 10-Q · filed 2016-08-15 | $358.00K derived: sum of 3 quarters · filed 2017-03-31 | $478.00K derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-03-31 | $47.00K 10-Q · filed 2016-05-16 | $165.00K derived: sum of 2 quarters · filed 2017-03-31 | $285.00K derived: sum of 3 quarters · filed 2017-03-31 | $486.00K derived: sum of 4 quarters · filed 2017-03-31 |
| 2014-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $238.00K derived: sum of 2 quarters · filed 2017-03-31 | $439.00K derived: sum of 3 quarters · filed 2017-03-31 | $504.00K 10-K · filed 2017-03-31 |
| 2014-09-30 | $120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $321.00K derived: sum of 2 quarters · filed 2015-11-16 | $386.00K 10-Q · filed 2015-11-16 | $537.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $201.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $266.00K 10-Q · filed 2015-08-12 | $417.00K derived: sum of 3 quarters · filed 2016-03-29 | $630.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | $65.00K 10-Q · filed 2015-05-12 | $216.00K derived: sum of 2 quarters · filed 2016-03-29 | $429.00K derived: sum of 3 quarters · filed 2016-03-29 | $719.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2013-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $364.00K derived: sum of 2 quarters · filed 2016-03-29 | $654.00K derived: sum of 3 quarters · filed 2016-03-29 | $898.00K 10-K · filed 2016-03-29 |
| 2013-09-30 | $213.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $503.00K derived: sum of 2 quarters · filed 2014-11-07 | $747.00K 10-Q · filed 2014-11-07 | $1.68M derived: sum of 4 quarters · filed 2015-03-19 |
| 2013-06-30 | $290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $534.00K 10-Q · filed 2014-08-08 | $1.47M derived: sum of 3 quarters · filed 2015-03-19 | $3.08M derived: sum of 4 quarters · filed 2015-03-19 |
| 2013-03-31 | $244.00K 10-Q · filed 2014-05-09 | $1.18M derived: sum of 2 quarters · filed 2015-03-19 | $2.79M derived: sum of 3 quarters · filed 2015-03-19 | $4.45M derived: sum of 4 quarters · filed 2015-03-19 |
| 2012-12-31 | $934.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $2.55M derived: sum of 2 quarters · filed 2015-03-19 | $4.20M derived: sum of 3 quarters · filed 2015-03-19 | $5.75M 10-K · filed 2015-03-19 |
| 2012-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $3.27M derived: sum of 2 quarters · filed 2013-11-08 | $4.82M 10-Q · filed 2013-11-08 | $5.77M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $3.21M 10-Q · filed 2013-08-09 | $4.16M derived: sum of 3 quarters · filed 2014-03-14 | $4.63M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $1.55M 10-Q · filed 2013-05-08 | $2.50M derived: sum of 2 quarters · filed 2014-03-14 | $2.97M derived: sum of 3 quarters · filed 2014-03-14 | $3.32M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $953.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $1.42M derived: sum of 2 quarters · filed 2014-03-14 | $1.77M derived: sum of 3 quarters · filed 2014-03-14 | $1.80M 10-K · filed 2014-03-14 |
| 2011-09-30 | $468.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $813.00K derived: sum of 2 quarters · filed 2012-11-02 | $849.00K 10-Q · filed 2012-11-02 | $1.06M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $345.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $381.00K 10-Q · filed 2012-08-08 | $596.00K derived: sum of 3 quarters · filed 2013-03-18 | $748.00K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $36.00K 10-Q · filed 2012-05-07 | $251.00K derived: sum of 2 quarters · filed 2013-03-18 | $403.00K derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $367.00K derived: sum of 2 quarters · filed 2013-03-18 | $729.00K 10-K · filed 2013-03-18 | |
| 2010-09-30 | $152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $514.00K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $362.00K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $332.00K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |